Author:
Ogiwara Kenichi,Nogami Keiji,Matsumoto Tomoko,Shima Midori
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Lusher JM. The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors. Scand J Haematol. 1984;40:195–202.
2. Lusher J, Ingerslev J, Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis. 1998;9:119–28.
3. Astermark J, Donfield SM, DiMichele DM, Gringeri A, Gilbert SA, Waters J, et al. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood. 2007;109:546–51.
4. Berntorp E. Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors. Haemophilia. 2009;15:3–10.
5. Stenbjerg S, Jorgensen J. Resistance to activated FIX concentrate (FEIBA). Scand J Haematol. 1977;18:421–6.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献